Guardant Health
GH
$16.67
Share price
1.71%
Change (1 day)
-32.10%
Change (1 year)
Categories
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.
Operating Margin for Guardant Health (GH)
Operating Margin as of April 2024 (TTM): -99.33%
According to Guardant Health 's latest financial reports and stock price the company's current Operating Margin is -99.33%. At the end of 2022 the company had an Operating Margin of -145.36%.
Operating Margin history for Guardant Health from 2018 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -145.36% | 41.27% |
| 2021 | -102.89% | 19.98% |
| 2020 | -85.76% | 163.69% |
| 2019 | -32.52% | -65% |
| 2018 | -92.92% | -44.34% |
| 2017 | -166.96% | -8.62% |
| 2016 | -182.71% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Neogen NEOG | -2.68% | -97.30% | 🇺🇸 USA |
 Natera NTRA | -54.91% | -44.72% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.